denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Energizing the Red Cell: Pyruvate Kinase Activators for Treatment of Hereditary Hemolytic Anemias
Hematology Disease Topics & Pathways:
Research, clinical trials, Sickle Cell Disease, Non-Biological therapies, Clinical Research, Genetic Disorders, Thalassemia, Hemoglobinopathies, drug development, Diseases, Therapies, metabolism, Pharmacology, Biological Processes, Metabolic Disorders, Study Population, Human
Session: Energizing the Red Cell: Pyruvate Kinase Activators for Treatment of Hereditary Hemolytic Anemias
Hematology Disease Topics & Pathways:
Research, clinical trials, Sickle Cell Disease, Non-Biological therapies, Clinical Research, Genetic Disorders, Thalassemia, Hemoglobinopathies, drug development, Diseases, Therapies, metabolism, Pharmacology, Biological Processes, Metabolic Disorders, Study Population, Human
Monday, December 11, 2023, 10:30 AM-11:45 AM
Disclosures: Grace: Sanofi: Consultancy; Agios: Consultancy, Research Funding; Novartis: Research Funding; Sobi: Research Funding.
See more of: Energizing the Red Cell: Pyruvate Kinase Activators for Treatment of Hereditary Hemolytic Anemias
See more of: Education Program
See more of: Education Program
Previous Presentation
|
Next Presentation >>